12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Isentress raltegravir regulatory update

FDA approved an expanded label for Merck's Isentress raltegravir to include use in combination with other drugs to treat HIV-1...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >